epirubicin has been researched along with Chromosome-Defective Micronuclei in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, SF; Al-Khedhairy, AA; Attia, SM; Bakheet, SA; Harisa, GI; Saquib, Q | 1 |
| Balansky, RM; Blagoeva, PM; Mircheva, TJ; Simeonova, MI | 1 |
2 other study(ies) available for epirubicin and Chromosome-Defective Micronuclei
| Article | Year |
|---|---|
Dexrazoxane mitigates epirubicin-induced genotoxicity in mice bone marrow cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bone Marrow Cells; Carcinogens; Cardiotonic Agents; Comet Assay; Dexrazoxane; DNA Breaks; Epirubicin; Male; Mice; Micronuclei, Chromosome-Defective; Micronucleus Tests; Mutagenicity Tests; Reactive Oxygen Species | 2016 |
Diminished genotoxicity of mitomycin C and farmorubicin included in polybutylcyanoacrylate nanoparticles.
Topics: Animals; Bone Marrow; Drug Carriers; Enbucrilate; Epirubicin; Female; Liver; Maternal-Fetal Exchange; Mice; Micronuclei, Chromosome-Defective; Micronucleus Tests; Mitomycin; Mutagenicity Tests; Mutagens; Pregnancy; Salmonella typhimurium | 1992 |